QLT reports operating loss for first quarter

QLT announced an operating loss of $7.8 million for the first quarter of 2014, a $600,000 increase from the same period in 2013, according to a news release. The increase was mainly attributed to more research and development spending. Loss per share from continuing operations was $0.13, equal to the loss reported in the first quarter of 2013. Research and development expenses related to the company’s synthetic retinoid program totaled $4.8 million for the first quarter, compared with $4.1 million in 2013. The increase was attributed to costs related to (Read more...)